Entity Details

Primary name PEX3_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionP56589
EntryNamePEX3_HUMAN
FullNamePeroxisomal biogenesis factor 3
TaxID9606
Evidenceevidence at protein level
Length373
SequenceStatuscomplete
DateCreated1998-12-15
DateModified2021-06-02

Ontological Relatives

GenesPEX3

GO terms

Show/Hide Table
GOName
GO:0005654 nucleoplasm
GO:0005777 peroxisome
GO:0005778 peroxisomal membrane
GO:0005779 integral component of peroxisomal membrane
GO:0005783 endoplasmic reticulum
GO:0005829 cytosol
GO:0006869 lipid transport
GO:0007031 peroxisome organization
GO:0008289 lipid binding
GO:0016020 membrane
GO:0016557 peroxisome membrane biogenesis
GO:0030674 protein-macromolecule adaptor activity
GO:0032991 protein-containing complex
GO:0032994 protein-lipid complex
GO:0045046 protein import into peroxisome membrane

Subcellular Location

Show/Hide Table
Subcellular Location
Peroxisome membrane

Domains

Show/Hide Table
DomainNameCategoryType
IPR006966 Peroxin-3FamilyFamily

Diseases

Show/Hide Table
Disease IDSourceNameDescription
617370 OMIMPeroxisome biogenesis disorder 10B (PBD10B)A moderately severe peroxisome biogenesis disorder belonging to the Zellweger disease spectrum. PBD10B is characterized by neonatal jaundice, dysmorphic features, delayed psychomotor development, axial hypotonia that can progress to severe spastic paraparesis with hyperreflexia, nephrocalcinosis, neurogenic bladder, nystagmus, and cataracts. Laboratory studies show increased levels of very long-chain fatty acids. Inheritance is autosomal recessive. The disease is caused by variants affecting the gene represented in this entry.
614882 OMIMPeroxisome biogenesis disorder complementation group 12 (PBD-CG12)A peroxisomal disorder arising from a failure of protein import into the peroxisomal membrane or matrix. The peroxisome biogenesis disorders (PBD group) are genetically heterogeneous with at least 14 distinct genetic groups as concluded from complementation studies. Include disorders are: Zellweger syndrome (ZWS), neonatal adrenoleukodystrophy (NALD), infantile Refsum disease (IRD), and classical rhizomelic chondrodysplasia punctata (RCDP). ZWS, NALD and IRD are distinct from RCDP and constitute a clinical continuum of overlapping phenotypes known as the Zellweger spectrum (PBD-ZSS). The disease is caused by variants affecting the gene represented in this entry.
614882 OMIMPeroxisome biogenesis disorder complementation group 12 (PBD-CG12)A peroxisomal disorder arising from a failure of protein import into the peroxisomal membrane or matrix. The peroxisome biogenesis disorders (PBD group) are genetically heterogeneous with at least 14 distinct genetic groups as concluded from complementation studies. Include disorders are: Zellweger syndrome (ZWS), neonatal adrenoleukodystrophy (NALD), infantile Refsum disease (IRD), and classical rhizomelic chondrodysplasia punctata (RCDP). ZWS, NALD and IRD are distinct from RCDP and constitute a clinical continuum of overlapping phenotypes known as the Zellweger spectrum (PBD-ZSS). The disease is caused by variants affecting the gene represented in this entry.